NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,131 filers reported holding NOVARTIS A G in Q1 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,692,000 | -11.2% | 19,798 | -1.9% | 0.33% | -19.7% |
Q4 2020 | $1,906,000 | +5.4% | 20,188 | -3.0% | 0.41% | -9.5% |
Q3 2020 | $1,809,000 | -0.2% | 20,806 | +0.2% | 0.46% | -4.8% |
Q2 2020 | $1,813,000 | +4.3% | 20,758 | -1.6% | 0.48% | -14.5% |
Q1 2020 | $1,739,000 | -9.8% | 21,092 | +3.6% | 0.56% | +17.4% |
Q4 2019 | $1,927,000 | +15.3% | 20,352 | +5.8% | 0.48% | +3.9% |
Q3 2019 | $1,672,000 | -7.9% | 19,242 | -3.2% | 0.46% | -15.5% |
Q2 2019 | $1,815,000 | +1.3% | 19,877 | +6.7% | 0.54% | -4.1% |
Q1 2019 | $1,792,000 | +15.9% | 18,637 | +3.4% | 0.56% | +2.0% |
Q4 2018 | $1,546,000 | +12.4% | 18,016 | +12.8% | 0.55% | +27.9% |
Q3 2018 | $1,376,000 | +45.6% | 15,976 | +27.7% | 0.43% | +32.8% |
Q2 2018 | $945,000 | -0.7% | 12,506 | +6.2% | 0.33% | -6.1% |
Q1 2018 | $952,000 | -1.1% | 11,780 | +2.7% | 0.35% | -0.6% |
Q4 2017 | $963,000 | -8.2% | 11,475 | -6.1% | 0.35% | -13.0% |
Q3 2017 | $1,049,000 | +13.5% | 12,215 | +10.3% | 0.40% | +8.4% |
Q2 2017 | $924,000 | +17.4% | 11,070 | +4.5% | 0.37% | +14.2% |
Q1 2017 | $787,000 | +134.9% | 10,595 | +130.3% | 0.32% | +129.8% |
Q4 2016 | $335,000 | – | 4,600 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |